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Background: Cyrtomium fortumei (J.) Smith is an important Chinese herbal medicine because of its biological
functions. However, systematic and comprehensive studies on the phytochemicals from Cyrtomium fortumei (J.)
Smith and their bioactivity are limited.
Results: Using the bioassay-guided technique, the ethyl acetate and n-BuOH extracts of the rhizomes of Cyrtomium
fortumei (J.) Smith were shown to exhibit good antitumor activities, consequently leading to the isolation of 23
compounds. All compounds were isolated from the plant for the first time. The inhibitory activities of these
compounds were investigated on tumor cells MGC-803, PC3, and A375 in vitro by MTT (thiazolyl blue tetrazolium
bromide) assay, and the results showed that pimpinellin (3) had potent cytotoxic activities against the three cell
lines, with the IC50 values of 14.4 ± 0.3 μM, 20.4 ± 0.5 μM, and 29.2 ± 0.6 μM, respectively. The mechanism of the
antitumor action indicated that pimpinellin inhibited the growth of MGC-803 cells via the induction of tumor cell
apoptosis, with apoptosis ratio of 27.44% after 72 h of treatment at 20 μM.
Conclusions: This study suggests that most of the compounds from the roots of Cyrtomium fortumei (J.) Smith
could inhibit the growth of human carcinoma cells. Moreover, pimpinellin inhibited the growth of tumor cells via
the induction of tumor cell apoptosis.Background
Cyrtomium fortumei (J.) Smith belongs to the Dryopteri-
daceae family which comprises approximately 14 genera
and 1700 species throughout the world, and is widely
spread in tropical and subtropical regions. The Chinese
Pharmacopoeia (2005 edition) listed Cyrtomium fortumei
(J.) Smith as an official drug, which showed that the
plant could be used as anticancer herbs [1]. In the past,
people used the rhizomes and extracts from the plant as
vermifuges [2]. The plant can be used to cure many dis-
eases, such as influenza, acute and chronic pharyngitis,
cancer, and migraine [3]. In addition, the herb was used
as antiviral agents to cure severe acute respiratory syn-
drome, a life-threatening viral respiratory illness believed
to be caused by a coronavirus [4]. Furthermore, phoro-
glucinols and flavonoids are known to display a wide* Correspondence: jhzx.msm@gmail.com
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reproduction in any medium, provided the orarray of pharmacological and biochemical actions, and
have been isolated from many species of the Dryopteri-
daceae family [5]. However, so far the constituents with
anticancer activity of the plant remain unclear. Thus it is
necessary to identify the potent antitumor compounds
from this plant.
We have recently investigated the chemical constitu-
ents of Cyrtomium fortumei (J.) Smith systematically,
and tested the antitumor activities of the extracts and
compounds. The current study was conducted to valid-
ate the medicinal use of Cyrtomium fortumei (J.) Smith.
23 compounds were isolated from the ethyl acetate and
n-BuOH extracts, and their structures were elucidated
to be protocate chaldehyde (1), woodwardinsauremethy-
lester (2), pimpinellin (3), trans-2-coumaric acid (4),
physcion (5), ursolic acid (6), sitost-4-en-3-one (7), betu-
lin (8), 30,40,5-Trihydroxy-3,7-dimethoxyflavone (9),
woodwardinic acid (10), sitosterol-3-O-β-D-glucopyra-
noside (11), sutchuenoside A (12), β-sitosterol (13),
kaempferol-3,7-O-α-L-dirhamnoside (14), (-)-epicatchin
(15), (+)-catechin hydrate (16), kaempferol (17), asiatic
acid (18), 2β,3β,23-tihydroxy-12-oleanen-28-oic acidl Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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acetyl-α-L-rhamnopyranoside) (21), 2α,3α,24-trihydrox-
yurs-12-en-28-oic acid (22), and kaempferol-3-O-α-L-
rhamnopyranoside-7-O-α-L-rhamopyranoside (23). All
compounds were isolated from Cyrtomium fortumei (J.)
Smith for the first time. The inhibitory activities of these
compounds were investigated on tumor cells MGC-803,
PC3, and A375 in vitro by MTT (thiazolyl blue tetrazo-
lium bromide) assay, and the results indicated that some
of the compounds showed good antitumor activities. It
was found that pimpinellin (PPI) had most potent cyto-
toxic activities against the three cell lines, with the IC50
values of 14.4 ± 0.3 μM, 20.4 ± 0.5 μM, and 29.2 ±
0.6 μM, respectively. However, no report was found on
apoptosis inducing activity of PPI. Subsequent staining
and flow cytometry (FCM) analysis indicated that PPI
could apoptosis in MGC-803 cells, with the highest




Dried rhizomes of Cyrtomium fortumei (J.) Smith
(10 kg) were cut into pieces and extracted with 80%
EtOH (3 × 40 L) under reflux, 6 h for the first time, 3 h
for the second time, and 1 h for the last time. The com-
bined EtOH extracts were evaporated to dryness to yield
a dried EtOH extract (424 g). The extract was suspended
in water and then extracted with petroleum ether
(10 L × 3 times), ethyl acetate (10 L × 3 times), and n-
BuOH (10 L × 3 times), respectively. Different extracts
solvent were then concentrated using evaporator under
vacuum at 50°C to afford the petroleum ether extract
(46 g), ethyl acetate extract (95 g), and n-BuOH extract
(110 g). MTT assay was used to evaluate their antitumor
activities. The results suggested that the antitumor
agents were mainly contained in ethyl acetate and n-
BuOH extracts. Further experiments were performed on
ethyl acetate and n-BuOH extracts to separate antitumor
compounds. The ethyl acetate and n-BuOH extracts
were subjected to column chromatography (CC) to yield
16 fractions. An activity-directed isolation process was
used to get compounds, and 23 compounds were
obtained from these fractions.
The isolated compounds were identified via spectro-
scopic analyses, including 1H- and 13C-NMR spectros-
copy. The results of the analyses were compared with
the NMR and IR data reported in literatures to identify
the chemical structures. All compounds were isolated
from Cyrtomium fortumei (J.) Smith for the first time.
Biological evaluation
The potential effect of the extracts from Cyrtomium for-
tumei (J.) Smith was investigated on the viability ofMGC-803, PC3, A375, and NIH3T3 cells using MTT
assay at the concentration of 20 μM, with ADM (Adria-
mycin) being used as the positive control and DMSO
being used as the negative control. The inhibitory per-
centage of cells was treated with 20 μM or 50 μg/mL of
each compound or extract for 72 h (Table 1). The results
showed that the ethyl acetate and n-BuOH extracts had
great antitumor activity, and PPI had good activities
against the three human cancer cell lines tested than
other compounds. The inhibitory ratios of PPI at 72 h
after treatment were 67.1% on MGC-803 cells, 57.2% on
PC3 cells, 45.8% on A375 cells, and 24.8% on NIH3T3
cells. It could be seen that PPI had good antitumor ac-
tivities and low cytotoxic effect on normal cell line
NIH3T3. Further experiments found that proliferation
of these three carcinoma cells were significantly inhib-
ited by PPI in a concentration-dependent manner, as
shown in Figure 1. The IC50 values of PPI against MGC-
803, PC3, and A375 cells were determined to be 14.4 ±
0.3 μM, 20.4 ± 0.5 μM, and 29.2 ± 0.6 μM, respectively,
which were lower than that on NIH3T3 cells (IC50 >
100 μM).
To determine whether the growth inhibitory activity of
PPI was related to the induction of apoptosis, the mor-
phological character changes of MGC-803 cells were
investigated using the AO/EB staining, Hoechst 33258
staining, and TUNEL assay.
The cell morphologic changes after PPI treatment
were assessed by fluorescence microscopy after AO/EB
staining [6]. AO is a vital dye that could penetrate the
normal cell membrane [7], whereas EB will stain only
those cells that have lost their membrane integrity [8].
The stained cells revealed four different types under a
fluorescence microscope: the chromatin of living cells
was green with normal structure; the chromatin of non-
apoptotic dead cells was red with normal structure; yel-
low coloration of early apoptotic cells with morphous in
the form of pycnosis; and orange coloration of late apop-
totic cells with morphous in the form of pycnosis [9-13].
With hydroxycamptothecine (HCPT) as positive control,
the cytotoxicity of PPI at a concentration of 20 μM
against MGC-803 cells for 24 h was detected via AO/EB
staining.
As can be seen in Figure 2A, green live MGC-803
cells with normal morphology were seen in the negative
control group. Green yellow or orange dots were
detected in the HCPT after 24 h. After cells were trea-
ted with PPI for 24 h, the nuclei stained as yellow green
or orange, and the morphology showed pycnosis, mem-
brane blebbing and cell budding. These phenomena
indicate PPI could induce apoptosis without any signifi-
cant cytotoxicity.
Live cells with uniformly light blue nuclei were treated
with Hoechst 33258 [14-17] and observed under a
Table 1 Growth inhibition effect of various constituents of Cyrtomium fortumei (J.) Smith on different cell lines
Test extracts and compounds Inhibitory Rate for Different Cell Lines (%, mean ± SD) a
MGC-803 b PC3 c A375 d NIH3T3 e
Petroleum ether extract f 56.7 ± 3.7 68.0 ± 1.9 60.5 ± 3.2 7.1 ± 3.8
Ethyl acetate extract f 80.3 ± 2.8 89.6 ± 1.5 88.7 ± 3.3 45.6 ± 4.0
n-BuOH extract f 87.2 ± 3.9 80.2 ± 2.4 85.2 ± 3.7 53.5 ± 8.6
ADM 93.2 ± 1.6 95.1 ± 2.6 95.2 ± 2.4 98.5 ± 1.7
Protocate chaldehyde (1) 17.8 ± 3.1 30.5 ± 2.4 25.7 ± 3.1 12.1 ± 3.7
Woodwardinsaure methylester (2) 47.9 ± 9.3 33.2 ± 2.8 41.4 ± 5.6 15.2 ± 2.6
PPI (3) 67.1 ± 5.3 57.2 ± 4.2 45.8 ± 7.8 24.8 ± 3.4
Physcion (5) 28.9 ± 2.2 20.7 ± 1.2 15.7 ± 5.9 4.5 ± 2.6
Ursolic acid (6) 52.6 ± 2.4 55.8 ± 3.1 43.2 ± 1.3 23.4 ± 3.3
Sitost-4-en-3-one (7) 35.8 ± 2.6 15.3 ± 5.8 26.4 ± 5.1 5.2 ± 2.7
Betulin (8) 45.1 ± 3.1 18.4 ± 3.1 33.9 ± 5.6 29.8 ± 2.5
30,40,5-Trihydroxy-3,7-dimethoxyflavone (9) 25.6 ± 3.9 20.3 ± 2.5 11.2 ± 6.2 10.0 ± 2.9
Woodwardinic acid (10) 25.1 ± 5.3 25.2 ± 1.3 38.6 ± 4.0 6.9 ± 2.0
Sutchuenoside A (12) 19.9 ± 9.8 12.3 ± 4.4 34.8 ± 5.3 8.8 ± 4.2
Kaempferol-3, 7-O-α-L-dirhamnoside (14) 21.5 ± 7.0 17.8 ± 5.5 36.7 ± 3.9 23.1 ± 3.2
(-)-Epicatchin (15) 45.5 ± 4.1 50.6 ± 1.6 45.3 ± 3.2 22.5 ± 3.8
(+)-Catechin hydrate (16) 52.1 ± 5.7 49.6 ± 2.3 46.8 ± 1.1 28.9 ± 4.3
Kampferol (17) 54.5 ± 2.4 44.3 ± 2.5 47.3 ± 1.9 12.2 ± 3.4
Crassirhizomoside A (20) 11.4 ± 2.3 20.8 ± 6.0 34.9 ± 2.7 12.5 ± 5.2
Kaempferol-3-O-(3-O-acetyl-α-L-rhamnopyranoside) (21) 22.6 ± 8.0 15.6 ± 6.1 17.8 ± 3.3 9.9 ± 6.1
Note: a Inhibitory percentage of cells treated with 20 μM of each compound for 72 h and SD = standard deviation; b Stomach cancer; c Prostate cancer; d
Malignant melanoma; e Mouse fibroblasts; f Inhibitory percentage of cells treated with 200 μg/mL of each extract for 72 h.
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bright blue nuclei because of karyopyknosis and chroma-
tin condensation; the nuclei of dead cells could not be
stained [18-22]. With hydroxycamptothecine (HCPT) asFigure 1 Effect of PPI on proliferation of tumor cells. After MGC-
803, PC3, and A375 cells were treated with PPI for 72 h in the
concentration varied from 1.25 to 50 μM, growth inhibition of those
tumor cells was detected by MTT assay.positive control, MGC-803 cells treated with PPI at
20 μM for 24 h were stained with Hoechst 33258.
As can be seen in Figure 2B, the cells of the negative
group (DMSO) were normal blue. However, the cells of
HCPT treatment appeared to be compact and con-
densed. After treatment with PPI for 24 h, most of cell
nuclei appeared to be highly condensed and crescent-
shaped, indicating that PPI induced apoptosis againstFigure 2 Apoptosis induction studies of PPI. (A) AO\EB staining.
(B) Hoechst 33258 staining. (C) TUNEL assay.
Figure 4 Effects of concentration of PPI on apoptosis. These
cells were treated with HCPT and PPI for 24, 48, and 72 h.
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AO/EB double staining.
In addition, TUNEL, one of the popular methods,
identified apoptotic cells in situ via the detection of
DNA fragmentation [23,24]. Under a biological micro-
scope, the cells were observed that where brown pre-
cipitate was the result of positive apoptosis [25-27].
MGC-803 cells were treated PPI and HCPT 20 μM at
with for 24 h.
As can be seen in Figure 2C, the cells of the negative
group (DMSO) did not appear as brown precipitates,
whereas both PPI and HCPT appeared as brown precipi-
tates. Therefore, it can be further concluded that PPI
induced apoptosis against MGC-803 cells. The results
were identical with the previous experiment.
The apoptosis ratios induced by PPI in tumor cells
was quantitatively assessed by FCM [28]. In early apop-
totic cells, phosphatidylserine (PS) which distributed in-
side the lipid bilayer in the normal cells was transferred
from the inside of the cell membrane to the outside.
Annexin V, a Ca2+ dependent phospholipid-binding pro-
tein with a high affinity for PS, was used to detect early
apoptotic cells. PI (Propidine Iodide) was a red fluores-
cent dye and stained cells that had lost membrane integ-
rity. So, the different periods of apoptotic cells could be
distinguished when Annexin V matched with PI: nec-
rotic cells (the upper left quadrant, Annexin-/PI+), late
apoptotic cells (the upper right quadrant, Annexin+/PI+),
intact cells (the lower left quadrant, Annexin-/PI-) and
early apoptotic cells (the lower right quadrant, Annexin
+/PI-) [29,30]. As shown in Figure 3, with HCPT as posi-
tive control, PPI could induce apoptosis of MGC-803
cells, with the highest apoptosis ratio of 27.44% at 72 h
after treatment at 20 μM. Furthermore, as shown in
Figure 4 the apoptosis of MGC-803 which treated with
PPI increased gradually in a time-dependent manner.Figure 3 FCM tested apoptosis detection assay on MGC-803 cells. The
Annexin V/PI staining. In the figure, A, B, and C: treat with HCPT (20 μM) fo
and 72 h.Conclusions
In this study, an activity-directed fractionation and puri-
fication process were used to isolate antitumor com-
pounds from the rhizomes of Cyrtomium fortumei (J.)
Smith. The ethyl acetate and n-BuOH extracts had good
antitumor activities, consequently leading to the isola-
tion of 23 compounds identified as protocate chaldehyde
(1), woodwardinsauremethylester (2), pimpinellin (3),
trans-2-coumaric acid (4), physcion (5), ursolic acid (6),
sitost-4-en-3-one (7), betulin (8), 30,40,5-trihydroxy-3,7-
dimethoxyflavone (9), woodwardinic acid (10), sitosterol-
3-O-β-D-glucopyranoside(11), sutchuenoside A (12), β-
sitosterol (13), kaempferol-3,7-O-α-L-dirhamnoside (14),
(-)-epicatchin (15), (+)-catechin hydrate (16), kaempferol
(17), asiatic acid (18), 2β,3β,23-tihydroxy-12-oleanen-
28-oic acid (19), crassirhizomoside A (20), kaempferol-
3-O-(3-O-acetyl-α-L-rhamnopyranoside) (21), 2α,3α,24-appearance of apoptosis cells was detected by flow cytometry using
r 24, 48, and 72 h; D, E, and F: treat with PPI (20 μM) for 24, 48,
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O-α-L-rhamnopyranoside-7-O-α-L-rhamopyranoside (23).
All compounds were isolated from Cyrtomium fortumei
(J.) Smith for the first time. The inhibitory activities of
these compounds were investigated on tumor cells MGC-
803, PC3, and A375 in vitro by MTT assay, and the results
showed that some of the compounds exhibited moderate
antiproliferative activities. PPI showed potent activities
on MGC-803, PC3, and A375 cell lines, with the IC50
values of 14.4 ± 0.3 μM, 20.4 ± 0.5 μM, and 29.2 ± 0.6 μM,
respectively. The apoptosis inducing activities of PPI on
MGC-803 cell lines were investigated through AO/EB
staining, Hoechst 33258 staining, TUNEL and FCM assay.
The results demonstrated that PPI could induce cell apop-
tosis of MGC-803 cells. Further studies of the specific
mechanisms of the compound on human malignant
tumors are currently underway.
Experimental
General procedures and reagents
The melting points of the products were determined
using an XT-4 binocular microscope (Beijing Tech
Instrument Co. Ltd., Beijing, China). Infrared spectra
were recorded on a Bruker VECTOR22 spectrometer in
KBr disks. 1H-NMR and 13C-NMR were recorded using
a JEOL-ECX500 spectrometer at 22°C, with tetramethyl-
silane as the internal standard and CDCl3, DMSO-d6,
CD3COCD3, or CD3OD as the solvent. Column chroma-
tography was performed using silica gel (200–300
meshes) (Qingdao Marine Chemistry Co., Qingdao,
China) and silica gel H (Qingdao Marine Chemistry Co.,
Qingdao, China), Sephadex LH-20 (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden), HP-20 (Mitsubishi
Chemical Corp., Toukyu Met, Japan), YMC RP-18 (YMC
Corp., Kyoto, Japan) and MCI-gel CHP 20P (Mitsubishi
Chemical Corp., Toukyu Met, Japan). All other chemi-
cals were of analytical reagent grade and used without
further purification.
Plant materials
Fresh samples of Cyrtomium fortumei were collected
from Longli, Guizhou Province in China, in August
2011. Prof. Qingde Long, Department of Medicine,
Guiyang Medical University, identified the plant mater-
ial. A voucher specimen was deposited at Guiyang
Medical University, Guiyang, China.
Extraction and isolation
Dried rhizomes of Cyrtomium fortumei (J.) Smith
(10 kg) were cut into pieces and extracted with 80%
EtOH (3 × 40 L) under reflux, 6 h for the first time, 3 h
for the second time and 1 h for the last time. The com-
bined EtOH extracts were evaporated to dryness to yield
a dried EtOH extract (424 g). The extract was suspendedin water and then extracted with petroleum ether
(10 L × 3 times), ethyl acetate (10 L × 3 times) and n-
BuOH (10 L × 3 times) respectively. The organic ethyl
acetate extract (95 g) was subjected to CC on silica gel
(200-300 mesh) eluted with a gradient of petroleum
ether-EtOAc (20/1, 10/1, 5/1, 2/1 and 1/1, v/v), and fi-
nally a mixture of chloroform and methanol (10/1, 5/1
and 1/1, v/v, respectively) to get 10 fractions, namely,
fraction 1-10. The fractions were monitored by TLC.
Fraction 3 (10 g) was applied to a silica gel (200-300
mesh) column eluted with petroleum ether-EtOAc (10:1
to 1:1) to yield Protocate chaldehyde (1, 30 mg), Wood-
wardinsauremethylester (2, 13 mg) and yield 7 fractions,
namely, Fraction 10-70. Fractions 20 and 50 were purified
using PTLC to yield Pimpinellin (3, 25 mg), Trans-2-
coumaric acid (4, 13 mg), and Physcion (5, 18 mg). Frac-
tions 60 and 70 was separated using silica gel (300-400
mesh) eluted with petroleum ether-EtOAc (10:1) to yield
Ursolic acid (6, 23 mg), Sitost-4-en-3-one (7, 14 mg),
and Betulin (8, 18 mg). Fraction 5 (8 g) was applied to a
silica gel H column eluted with CHCl3-MeOH (10:1 to
5:1) to yield a yellow powder (3 g), and purified using a
Sephadex LH-20 column eluted with MeOH to yield
30,40,5-Trihydroxy-3,7-dimethoxyflavone (9, 15 mg). The
yellow powder was purified using silica gel repeatedly, to
yield Woodwardinic acid (10, 32 mg), Sitosterol-3-O-β-
D-glucopyranoside (11, 43 mg), and Sutchuenoside A
(12, 16 mg). Fraction 6 (13 g) was applied to a silica gel
H column eluted with CHCl3-MeOH (8:1 to 2:1) to yield
2 fractions, namely fraction A and B. Fraction A was
purified using a Sephadex LH-20 column eluted with
CHCl3-MeOH (1:1) to yield β-sitosterol (13, 24 mg), and
kaempferol-3,7-O-α-L-dirhamnoside (14, 25 mg). Frac-
tion B was recrystallized with acetone to give compound
(-)-Epicatchin (15, 13 mg).
The n-BuOH extract (110 g) was suspended in H2O,
adsorbed on an MCI-gel column (500 g), and eluted
using mixtures of H2O and MeOH starting with 20%
MeOH (v/v) to 100% MeOH in 10% increments (2.5 L
each fraction) to afford a total of 6 fractions, namely
fraction 11-16. The fractions were also monitored by
RP-TLC. Fraction 12 (6 g) was decolorized and separated
on MCI-gel eluted with 50-70% MeOH-H2O to yield
(+)-Catechin hydrate (16, 30 mg) and Kaempferol (17,
12 mg). Fraction 13 (12 g) was further chromatographed
on a YMC RP-18 column (50 μm) and eluted using a
MeOH-H2O gradient solvent system (50:50 to 90:10) to
yield Asiatic acid (18, 14 mg), 2β,3β,23-tihydroxy-12-
oleanen-28-oic acid (19, 16 mg), and a yellow powder
(2 g). The yellow powder was further purified over a
Sephadex LH-20 column and eluted with CHCl3-MeOH
(1:1) to yield Crassirhizomoside A (20, 22 mg) and sub-
fraction (A1-A4). Fraction A2 was separated using silica
gel (300-400 mesh) and purified through Sephadex LH-
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pyranoside) (21, 14 mg). Fraction A3 was purified with
silica gel (300-400 mesh) to yield 2α,3α,24-trihydrox-
yurs-12-en-28-oic acid (22, 16 mg). Fraction 14 (11 g)
were separated using HP-20 resin eluted with 60%-
90% MeOH-H2O and purified using a Sephadex LH-
20 column eluted with MeOH to yield Kaempferol-3-
O-α-L-rhamnopyranoside-7-O-α-L-rhamopyranoside
(23, 23 mg).
All spots on TLC were visualized by heating silica gel
plates sprayed with 10% Phosphomolybdic acid hydrate
in EtOH and 1% FeCl3 in EtOH.Spectroscopic data
Protocate chaldehyde (1). Yellow powder, mp 151-153°C.
1H-NMR (CD3OD, 500 MHz) δ: 9.63 (1H, s, CHO), 7.23
(2H, m, H-6, -2), 6.86 (1H, d, J = 5 Hz, H-5). 13C-NMR
(CD3OD, 125 MHz) δ: 192.1 (-CHO), 152.4 (C-4), 145.7
(C-3), 129.3 (C-1), 125.49 (C-6), 115.0 (C-5), 114.3 (C-2).
The above data were identical to the literature data [31].
Woodwardinsauremethylester (2). White powder, mp
201-203°C. IR (KBr, cm−1) νmax: 3480, 1738, 1630, 890.
1H-NMR (CDCl3, 500 MHz) δ: 4.75 (2H, s, H-30),
3.67 (3H, s, COOCH3), 1.63 (3H, s, Me), 1.17 (3H, s,
Me), 0.99 (3H, s, Me), 0.85 (3H, s, Me), 0.83 (3H, s, Me),
0.61 (3H, s, Me). 13C-NMR (CDCl3, 125 MHz) δ: 181.2
(COOCH3), 148.8 (C-30), 109.8 (C-22), 66.4 (C-3), 57.3
(COOCH3), 19.7 (C-29), 19.5 (C-26), 17.8 (C-27), 16.6
(C-28), 16.3 (C-25), 16.0 (C-24), The above data were
identical to the literature data [32].
Pimpinellin (3). Pale yellow powder, mp 118-120°C. IR
(KBr, cm−1) νmax: 1724, 1613, 1576, 1060.
1H-NMR
(CDCl3, 500 MHz) δ: 8.07 (1H, d, J = 10 Hz, H-4), 7.64
(1H, d, J = 1.5 Hz, H-12), 7.05 (1H, d, J = 3 Hz,H-11),
6.34 (1H, d, J = 10 Hz,H-3), 4.12 (3H, s, OCH3), 4.01
(3H, s, OCH3).
13C-NMR (CD3OD, 125 MHz) δ: 160.9
(C-2), 149.8 (C-7), 145.4 (C-12), 144.4 (C-9), 143.2 (C-5),
140.0 (C-4), 135.2 (C-6), 114.2 (C-3), 113.8 (C-8), 109.5
(C-10), 104.3 (C-11), 62.4 (OCH3), 61.3 (OCH3). The
above data were identical to the literature data [33].
Trans-2-coumaric acid (4). White powder, mp 189-
191°C. 1H-NMR (CD3OD, 500 MHz) δ: 7.99 (1H, d, J =
1.5 Hz, H-10), 7.19 (1H, m, H-4), 6.94 (1H, m, H-4), 6.86
(1H, m, H-3), 6.57 (1H, d, J = 2 Hz, H-20). 13C-NMR
(CD3OD, 125 MHz) δ: 168.0 (C = O), 156.6 (C-2), 140.5
(C-10), 131.5 (C-4), 128.9 (C-6), 121.5 (C-1), 120.0 (C-5),
117.9 (C-3), 116.2 (C-20). The above data were identical
to the literature data [34].
Ursolic acid (6). White powder, mp 257–259°C. IR
(KBr, cm−1) νmax: 3444, 2928, 2868, 1683, 1458, 1028.
1H-NMR (CD3OD, 500 MHz) δ: 0.78 (CH3, d, J = 10 Hz,
H-29), 0.84 (CH3, d, J = 10 Hz, H-30), 0.90 (CH3, s, H-
23), 0.92 (CH3, s, H-26), 0.97 (CH3, s, H-25), 1.09 (CH3,s, H-27), 3.20 (1H, d, J = 5 Hz, H-3), 5.2 (1H, t, J =
1.5 Hz, H-12). 13C-NMR (CD3OD, 125 MHz) δ: 180.1
(C-28), 138.3 (C-13), 125.6 (C-12), 78.1 (C-3), 55.4 (C-
5), 53.1 (C-18), 41.9 (C-14), 39.5 (C-8), 39.1 (C-19), 38.9
(C-1), 38.7 (C-4), 38.5 (C-20), 36.8 (C-10), 36.7 (C-22),
33.0 (C-7), 30.4 (C-21), 27.9 (C-23), 27.4 (C-15), 26.6
(C-2), 24.2 (C-16), 23.0 (C-11), 22.7 (C-27), 21.2 (C-30),
18.3 (C-6), 16.5 (C-26), 16.2 (C-29), 14.7 (C-25), 14.6
(C-24). The above data were identical to the literature
data [35].
Sitost-4-en-3-one (7). White crystalline, mp 90-92°C.
IR (KBr, cm−1) νmax: 2940, 1688, 1390, 867.
1H-NMR
(CDCl3, 500 MHz) δ: 5.58 (1H, d, J = 1.5 Hz, H-4), 1.07
(3H, s, H-19), 0.88 (3H, m, H-29), 0.71 (3H, s, H-18).
13C-NMR (CD3OD, 125 MHz) δ: 199.6 (C-3), 171.74 (C-
5), 123.68 (C-4), 55.9 (C-17), 55.8 (C-14), 53.7 (C-9),
45.8 (C-24), 42.3 (C-13), 39.5 (C-12), 38.6 (C-10), 36.1
(C-20), 35.6 (C-8), 35.5 (C-1), 33.9 (C-22), 33.9 (C-2),
32.9 (C-6), 32.0 (C-7), 29.1 (C-25), 28.1 (C-16), 26.0 (C-
23), 24.1 (C-15), 23.0 (C-28), 21.0 (C-11), 19.8 (C-26),
19.0 (C-27), 18.7 (C-21), 17.3 (C-19), 11.9 (C-29), 11.9
(C-18). The above data were identical to the literature
data [36].
Betulin (8). White powder, mp 234–236°C. IR (KBr,
cm−1) νmax: 3498, 2941, 1456, 1033.
1H-NMR (CDCl3,
500 MHz) δ: 3.79 (1H, d, J = 10 Hz, H-3), 4.67 (1H, s, H-
29), 4.56 (1H, s, H-29), 3.77 (1H, d, J = 5 Hz, H-28), 3.31
(1H, d, J = 10 Hz, H-28), 3.18 (1H, d, J = 5.5 Hz, H-3),
1.66 (3H, s, H-30). 13C-NMR (CDCl3, 125 MHz) δ: 150.5
(C-20), 109.7 (C-29), 79.0 (C-3), 60.6 (C-28), 55.3 (C-5),
50.4 (C-9), 48.8 (C-18), 47.8 (C-17, 19), 42.7 (C-14), 40.9
(C-8), 38.9 (C-4), 38.7 (C-1), 37.4 (C-13), 37.2 (C-10),
34.2 (C-7), 34.0 (C-22), 29.8 (C-21), 29.2 (C-16), 28.0 (C-
23), 27.4 (C-2), 27.1 (C-15), 25.3 (C-12), 20.8 (C-11),
19.1 (C-30), 18.4 (C-6), 16.1 (C-25), 16.0 (C-26), 15.4 (C-
24), 14.8 (C-27). The above data were identical to the lit-
erature data [37].
30,40,5-Trihydroxy-3,7-dimethoxyflavone (9). Yellow pow-
der, mp 233-235°C. IR (KBr, cm-1) νmax 3455, 1642, 1531.
1H-NMR (CD3OD, 500 MHz) δ: 7.47 (1H, d, J= 3 Hz,
H-20), 6.85 (1H, d, J= 10 Hz, H-50), 6.45 (1H, d, J= 2.5 Hz,
H-8), 6.35 (1H, d, J = 3 Hz, H-6), 3.86 (3H, s, OCH3) 3.73
(3H, s, OCH3).
13C-NMR (CD3OD, 125 MHz) δ: 174.8
(C-4), 162.4 (C-7), 161.1 (C-9), 158.8 (C-5), 154.8 (C-2),
148.1 (C-40), 145.0 (C-30), 140.0 (C-3), 121.7 (C-10), 120.6
(C-60), 115.0 (C-20), 114.9 (C-50), 107.3 (C-10), 95.7 (C-6),
94.6 (C-8), 58.8 (OCH3), 55.1 (OCH3). The above data were
identical to the literature data [38].
Woodwardinic acid (10). White powder, mp 242-244°C.
IR (KBr, cm−1) νmax: 3490, 1709, 1635, 886.
1H-NMR
(DMSO-d6, 500 MHz) δ: 4.75 (2H, s, H-30), 1.69 (3H, s,
Me), 1.24 (3H, s, Me), 1.10 (3H, s, Me), 0.95 (3H, s, Me),
0.92 (3H, s, Me), 0.69 (3H, s, Me). 13C-NMR (DMSO-d6,
125 MHz) δ: 180.3 (C-23), 148.3 (C-30), 110.3 (C-22),
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28), 16.0 (C-24), 16.0 (C-25). The above data were identi-
cal to the literature data [39].
Sutchuenoside A (12). Pale yellow amorphous powder,
mp 211-213°C. IR (KBr, cm−1) νmax: 3455, 1701, 1623.
1H-
NMR (CD3OD, 500 MHz) δ: 7.74 (2H, d, J = 9 Hz, H-2
0,
-60), 6.94 (2H, d, J = 9 Hz, H-30, -50), 6.71 (1H, d, J = 1 Hz,
H-8), 6.45 (1H, d, J = 1 Hz, H-6), 5.57 (1H, br s, H-1″),
5.50 (1H, s, 2‴-OH), 4.52 (1H, s, 3‴-OH), 4.19 (1H, br s,
H-2″), 3.92 (1H, br s, H-2‴), 3.82 (1H, m, H-3″), 3.58
(1H, m, H-3‴), 3.45 (1H, m, H-5‴), 3.21-3.25 (2H, m, H-
4‴, -5″), 2.08 (3H, s, Ac), 1.25 (3H, d, J = 6.5 Hz, Me-6‴),
0.77 (3H, d, J = 5 Hz, Me-6″). 13C-NMR (CD3OD,
125 MHz) δ: 178.3 (C-4), 171.0 (COCH3), 162.2 (C-7),
161.6 (C-5), 160.5 (C-40), 158.6 (C-2), 156.8 (C-9), 134.5
(C-3), 130.7 (C-30,-50), 120.9 (C-10), 115.2 (C-20,-60), 106.2
(C-10), 101.2 (C-10), 99.3 (C-6), 98.5 (C-1‴), 94.3 (C-8),
73.5 (C-4″), 72.2 (C-4‴), 70.7 (C-3‴), 70.3 (C-5‴), 70.3
(C-2″), 69.9 (C-2‴), 68.6 (C-5″), 68.3 (C-3″), 19.6
(COCH3), 17.0 (C-6″), 16.2 (C-6″). The above data were
identical to the literature data [40].
Kaempferol-3,7-O-α-L-dirhamnoside (14). Light yel-
low crystals, mp 175-177°C. IR (KBr, cm−1) νmax: 3347,
2912, 1613, 876. 1H-NMR (CD3OD, 500 MHz) δ: 7.78
(2H , d, J = 8.5 Hz), 6.92 (2H , d, J = 8.5 Hz), 6.70(1H, d,
J = 2 Hz), 6.44 (1H, d, J = 2.5 Hz), 5.54 (1H, br s, H-1″),
5.38 (1H, br s, 2‴-OH), 1.24 (3H, d, J = 6 Hz, Me-6‴),
0.91(3H, d, J = 5.5 Hz, Me-6‴). 13C-NMR (CD3OD,
125 MHz) δ: 178.4 (C-4), 162.2 (C-7), 160.4 (C-40), 158.4
(C-2), 156.7 (C-9), 135.1 (C-3), 162.2 (C-5), 99.2 (C-6),
94.2 (C-8), 121.0 (C-10), 115.2 (C-20,-60), 130.7 (C-30,-50),
106.2 (C-10), 102.1 (C-1″), 98.5 (C-1‴), 72.2 (C-4″),
71.8 (C-4‴), 70.7 (C-2″), 70.7 (C-5‴), 70.7 (C-3‴), 70.5
(C-2‴), 70.3 (C-5″), 69.9 (C-3″), 16.7 (C-6‴), 16.3
(C-6″). The above data were identical to the literature
data [41].
(-)-Epicatchin (15). White powder, mp 222-224°C. IR
(KBr, cm-1) νmax 3440, 1622, 1461, 1289;
1H NMR
(CD3OD, 500 MHz) δ: 6.79 (1H, d, J = 5 Hz, H-6
0), 6.75
(1H, d, = 15 Hz, H-20), 6.70 (1H, d, J = 1.5 Hz, H-5), 5.93
(1H, d, J = 3 Hz, H-8), 5.84 (1H, d, J = 1.5 Hz, H-6), 4.80
(1H, s, H-2), 2.85 (1H, dd, J = 10 Hz, 12.5 Hz, H-3), 2.48
(1H, dd, J = 12 Hz, 10 Hz, H-4); 13C NMR (CD3OD,
125 MHz) δ: 156.8 (C-9), 156.2 (C-7), 155.5 (C-5), 144.8
(C-30), 144.9 (C-40), 130.9 (C-10), 118.0 (C-60), 114.7 (C-
20), 113.9 (C-50), 98.7 (C-10), 95.0 (C-6), 94.5 (C-8), 78.5
(C-2), 66.1 (C-3), 27.9 (C-4). The above data were identi-
cal to the literature data [42].
(+)-Catechin hydrate (16). White powder, mp 134-
136°C. IR (KBr, cm-1) νmax 3350, 1635, 1511;
1H-NMR
(CD3OD, 500 MHz) δ: 6.81 (1H, d, J = 1 Hz, H-2
0), 6.72
(1H, d, J = 8 Hz, H-60), 6.70 (1H, d, J = 1.5 Hz, H-5), 5.90
(1H, d, J = 3 Hz, H-8), 5.82 (1H, d, J = 2 Hz, H-6), 4.54
(1H, d, J = 7 Hz, H-2), 2.83 (1H, dd, J = 5, 15 Hz, H-3),2.47 (1H, dd, J = 14, 10 Hz, H-4).13C-NMR (CD3OD,
125 MHz) δ: 156.5 (C-7), 156.2 (C-9), 155.6 (C-5), 144.9
(C-40), 144.9 (C-30), 130.8 (C-10), 118.7 (C-60), 114.7 (C-50),
113.9 (C-20), 99.5 (C-10), 94.9 (C-6), 94.1 (C-8), 81.5 (C-2),
67.4 (C-3), 27.2 (C-4). The above data were identical to
the literature data [43].
Kampferol (17). Yellow powder, mp 279-281°C. IR
(KBr, cm-1) νmax 3409, 1649, 1511;
1H-NMR (CD3OD,
500 MHz) δ: 12.48 (1H, s, C-5-OH), 7.98 (2H, d, J =
1.5 Hz, H-20, H-60), 6.88 (2H, d, J = 4 Hz, H-30, H-50),
6.35 (1H, d, J = 1 Hz, H-8), 6.11 (1H, d, J = 1.5 Hz, H-6).
13C-NMR (CD3OD, 125 MHz) δ: 175.8 (C-4), 164.1 (C-
7), 161.2 (C-9), 159.2 (C-40), 156.9 (C-5), 146.2 (C-2),
135.8 (C-60), 129.6 (C-20), 122.5 (C-10), 115.5 (C-50),
115.4 (C-30), 103.3 (C-10), 98.3 (C-6), 93.7(C-8). The
above data were identical to the literature data [44].
Asiatic acid (18). White powder, mp 233-235°C. IR
(KBr, cm−1) νmax: 3428, 3380, 1688, 1375, 920.
1H-NMR
(CD3OD, 500 MHz) δ: 1.06 (3H, s, H-25), 0.99 (9H, s,
H-24, 26, 27), 0.90 (3H, d, J = 8 Hz, H-29), 0.84 (3H, d, J
= 1.5 Hz, H-30). 13C-NMR (CD3OD, 125 MHz) δ: 179.7
(C-28), 139.1 (C-13), 125.4 (C-12), 77.9 (C-3), 68.7 (C-2),
66.3 (C-23), 53.4 (C-18), 47.9 (C-17), 47.9 (C-5), 47.7
(C-9), 47.7 (C-1), 43.4 (C-14), 42.3 (C-4), 39.9 (C-8), 39.8
(C-20), 39.3 (C-19), 39.2 (C-10), 37.2 (C-22), 33.0 (C-7),
30.9 (C-21), 28.4 (C-15), 24.7 (C-16), 23.7 (C-11), 23.5
(C-27), 21.2 (C-30), 18.3 (C-6), 17.3 (C-29), 17.3 (C-26),
17.3 (C-25), 14.3 (C-24). The above data were identical
to the literature data [45].
2β,3β,23-tihydroxy-12-oleanen-28-oic acid (19). White
powder, mp 212-215°C. IR (KBr, cm−1) νmax: 3410-3385,
1688, 1355. 1H-NMR (CD3OD, 500 MHz) δ: 5.38 (H, br
s, H-12), 3.72 (1H, br s, H-3), 3.21 (1H, dd, J = 4,
10.5 Hz, H-18), 1.25, 1.22, 1.11, 1.05, 0.96 (15H, s, H-25,
26, 27, 29, 30). 13C-NMR (CD3OD, 125 MHz) δ: 180.0
(C-28), 144.6 (C-13), 122.3 (C-12), 74.0 (C-3), 66.0
(C-24), 65.0 (C-2), 53.3 (C-18), 49.2 (C-5), 47.8 (C-9),
46.2 (C-17), 45.0 (C-4), 41.7 (C-1), 41.4 (C-14), 39.2
(C-10), 39.2 (C-8), 39.8 (C-19), 34.0 (C-22), 33.8 (C-21),
33.5 (C-7), 33.0 (C-29), 30.9 (C-20), 28.4 (C-15), 25.9
(C-27), 25.0 (C-16), 23.9 (C-23), 23.9 (C-11), 23.7 (C-30),
17.3 (C-6), 17.0 (C-25), 16.9 (C-26). The above data were
identical to the literature data [46].
Crassirhizomoside A (20). Pale yellow amorphous
powder, mp 192-194°C. IR (KBr, cm−1) νmax: 3428, 1745,
1655, 1610. 1H-NMR (CD3OD, 500 MHz) δ: 7.73 (2H, d,
J = 10 Hz, H-20, 60), 6.93 (2H, d, J = 10 Hz, H-30, 50), 6.71
(1H, br s, H-8), 6.44 (1H, br s, H-6), 2.09 (3H, s,
COCH3-4″), 2.02 (3H, s, COCH3-2″), 1.24 (3H, d, J =
2.5 Hz, H-6‴), 0.80 (3H, d, J = 3.5 Hz, H-6″). 13C-NMR
(CD3OD, 125 MHz) δ: 178.0 (C-4), 170.9 (4″-COCH3),
170.8 (2″-COCH3), 162.2 (C-5), 162.2 (C-4
0), 161.6
(C-7), 160.6(C-2), 156.7 (C-9), 133.9 (C-3), 130.6 (C-60),
130.6 (C-20), 120.7 (C-10), 115.3 (C-50), 115.3 (C-30),
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(C-8), 73.3 (C-4″), 73.3 (C-4‴), 73.3 (C-2″), 72.2 (C-3″),
69.9 (C-5‴), 69.9 (C-2‴), 68.3 (C-5″), 67.0 (C-3″), 19.5
(4″-COCH3), 19.5 (2″-COCH3), 16.7 (C-6‴), 16.2 (C-6″).
The above data were identical to the literature data [47].
Kaempferol-3-O-(3-O-acetyl-α-L-rhamnopyranoside)
(21). Pale yellow amorphous powder, mp 181-183°C. IR
(KBr, cm−1) νmax: 3398, 1744, 1603, 994.
1H-NMR
(CD3OD, 500 MHz) δ: 7.70 (2H, d, J = 8 Hz, H-2
0, 60),
6.91 (2H, d, J = 5 Hz, H-30, 50), 6.34 (1H, d, J = 2 Hz, H-
8), 6.20 (1H, d, J = 2 Hz, H-6), 5.45 (1H, d, J = 2.5 Hz, H-
1″), 4.40 (1H, m, H-2″), 2.02 (3H, s, COOCH3).
13C-
NMR (CD3OD, 125 MHz) δ: 159.1 (C-2), 135.3 (C-3),
179.1 (C-4), 172.5 ( COCH3), 165.2 (C-7), 162.4 (C-4
0),
160.9 (C-5), 158.1 (C-9), 131.6 (C-20, 60), 122.2 (C-10),
116.3 (C-30, 50), 106.0 (C-10), 102.1 (C-1″), 100.0 (C-6),
95.0 (C-8), 74.7 (C-3″), 71.3 (C-5″), 70.0 (C-4″), 69.0
(C-2″), 21.5 (COCH3), 17.7 (C-6″). The above data were
identical to the literature data [48].
2α,3α,24-trihydroxyurs-12-en-28-oic acid (22). White
powder, mp 204-206°C. IR (KBr, cm−1) νmax: 3420-3390,
1690, 1365, 910. 1H-NMR (CD3OD, 500 MHz) δ: 3.72
(1H, br s, H-3), 2.13 (1H, d, J = 5.5Hz, H-18), 1.11 (3H,
s, H-25), 1.06 (9H, s, H-24, 26, 27), 0.94 (3H, d, J = 5 Hz,
H-29), 0.86 (3H, d, J = 2 Hz, H-30). 13C-NMR (CD3OD,
125 MHz) δ: 179.7 (C-28), 138.5 (C-13), 125.3 (C-12),
73.2 (C-3), 65.6 (C-24), 64.5 (C-2), 53.1 (C-18), 44.1
(C-4), 41.4 (C-14), 41.3 (C-1), 39.5 (C-19), 39.1 (C-20),
39.1 (C-10), 39.1 (C-8), 37.8 (C-22), 33.2 (C-7), 29.4 (C-
21), 27.8 (C-15), 24.0 (C-16), 23.2 (C-11), 22.8 (C-23),
21.9 (C-27), 20.3 (C-30), 17.9 (C-29), 17.9 (C-6), 16.4 (C-
26), 16.4 (C-25). The above data were identical to the lit-
erature data [49].
Kaempferol-3-O-α-L-rhamnopyranoside-7-O-α-L-rha-
mopyranoside (23). Yellow powder, mp 200-202°C. IR
(KBr, cm−1) νmax: 3420, 2911, 1651, 1605, 1022.
1H-
NMR (CD3OD, 500 MHz) δ: 7.78 (2H, d, J = 7 Hz, H-2
0,
-60), 6.92 (2H, d, J = 5.5 Hz, H-30, -50), 6.71(1H, d, J =
1.5 Hz, H-8), 6.44 (1H, d, J = 1.5 Hz, H-6), 5.54 (1H, br
s, H-1″), 5.38 (1H, s, 2‴-OH), 4.57 (1H, br s, H-2″),
4.00 (1H, br s, H-2‴), 3.80 (1H, m, H-3″), 3.59 (1H, m,
H-3‴). 13C-NMR (CD3OD, 125 MHz) δ: 178.4 (C-4),
162.2 (C-7), 161.6 (C-5), 160.4 (C-40), 158.4 (C-2), 156.7
(C-9), 135.1 (C-3), 130.6 (C-30,-50), 121.0 (C-10), 115.2
(C-20, -60), 106.2 (C-10), 102.1 (C-1″), 99.2 (C-6), 98.5
(C-1‴), 94.2 (C-8), 72.3 (C-2″), 71.8 (C-4‴), 70.8 (C-
4″), 70.7 (C-3‴), 70.7 (C-5‴), 70.5 (C-3″), 70.3 (C-2‴),
69.9 (C-5″), 16.7 (C-6‴), 16.4 (C-6″). The above data
were identical to the literature data [50].
Cell lines and culture
MGC-803, PC3, A375, and NIH3T3 cell lines were
obtained from the Institute of Biochemistry and Cell
Biology, China Academy of Science. MGC-803 is stomachcancer cell line, PC3 is prostate cancer cell line, A375 is
malignant melanoma cell line, and NIH3T3 is mouse
fibroblast cell line. The entire cancer cell lines were main-
tained in the RPMI 1640 medium and NIH3T3 was main-
tained in the DMEM medium. They were supplemented
with 10% heat-inactivated fetal bovine serum (FBS) in a
humidified atmosphere of 5% CO2 at 37°C. All cell lines
were maintained at 37°C in a humidified 5% carbon diox-
ide and 95% air incubator.
MTT assay
All tested extracts and compounds were dissolved in
DMSO and subsequently diluted in the culture medium
before treatment of the cultured cells. When the cells
were 80-90% confluent, they were harvested by treatment
with a solution containing 0.25% trypsin, thoroughly washed
and resuspended in supplemented growth medium. Cells
(2 × 103/well) were plated in 100 μL of medium/well in 96-
well plate. After incubations overnight, the cells were treated
with different concentrations of extracts in RPMI 1640 with
10% FBS for 72 h. In parallel, the cells treated with 0.1%
DMSO served as negative control and ADM (Adriamycin)
as positive control. Finally, 100 μL of MTT (Beyotime Co.,
Jiangsu, China) was added, and the cells were incubated for
4 h. The MTT-formazan formed by metabolically viable
cells was dissolved in 100 μL of SDS for 12 h. The absorb-
ance was then measured at 595 nm with a microplate reader
(BIO-RAD, model 680), which is directly proportional to the
number of living cells in culture [51].
AO/EB staining
The cells were seeded at a concentration of 5 × 104 cell/
mL in a volume of 0.6 mL on a sterile cover slip in 6-
well tissue culture plates. Following incubation, the
medium was removed and replaced with fresh medium
plus 10% FBS and then supplemented with compounds.
After the treatment period, the cover slip with mono-
layer cells was inverted on the glass slide with 20 μL of
AO/EB (Beyotime Co., Shanghai, China) stain (100 μg/
mL). The fluorescence was read using an IX71SIF-3
fluorescence microscope (OLYMPUS Co., Toukyu Met,
Japan).
Hoechst 33258 staining
The cells grown on the sterile cover slip in 6-well tissue
culture plates were treated with compounds for a certain
range of treatment time. The culture medium containing
compounds was removed, and the cells were fixed in 4%
paraformaldehyde for 10 min. The cells were washed
twice with PBS, and were consequently stained with
0.5 mL of Hoechst 33258 staining (Beyotime Co.,
Jiangsu, China) for 5 min. The stained nuclei were
washed twice with PBS, and were consequently observed
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excitation and 460 nm emissions.
TUNEL assay
TUNEL assays were performed using a colorimetric
TUNEL apoptosis assay kit according to the manufac-
turer’s instructions (Beyotime). The cells grown in 6-well
culture clusters were treated as mentioned in mitochon-
drial depolarization assay. The MGC-803 cells grown in
6-well tissue culture plates were washed with PBS and
fixed in 4% paraformaldehyde for 40 min. The cells were
washed once with PBS, and were consequently permea-
bilized with immunol staining wash buffer (Beyotime)
for 2 min on ice. The cells were rewashed once with
PBS, and were consequently incubated in 0.3% H2O2 in
methanol at room temperature for 20 min to inactivate
the endogenous peroxidases, after which the cells were
washed thrice with PBS. Thereafter, the cells were incu-
bated with 2 μL of TdT-enzyme and 48 μL of Biotin-
dUTP per specimen for 60 min at 37°C. The cells were
terminated for 10 min, and were consequently incubated
with streptavidin-HRP (50 μL per specimen) conjugate
diluted at 1:50 in sample diluent for 30 min. The cells
were washed three times with PBS, and were conse-
quently incubated with diaminobenzidine solution (200
μL per specimen) for 10 min. Thereafter, the cells were
rewashed twice with PBS, and were consequently imaged
under an XDS-1B inverted biological microscope (Chong-
qing Photoelectric Devices Co. Chongqing, China).
Flow cytometry analysis
Prepared MGC-803 cells (1 × 106/mL) were washed
twice with cold PBS and then re-suspended gently in
500 μL binding buffer. Thereafter, cells were stained in 5
μL Annexin V-FITC and shaked well. Finally, 5 μL PI
was added to these cells and incubated for 20 min in a
dark place, analyzed by FACS Calibur, Becton Dickinson.
Statistical analysis
All statistical analyses were performed using SPSS 10.0,
and the data were analyzed using one-way ANOVA. The
mean separations were performed using the least signifi-
cant difference method. Each experiment was performed
in triplicate, and all experiments were run thrice and
yielded similar results. Measurements from all the repli-
cates were combined, and the treatment effects were
analyzed.
Competing interests
All the authors declare that they have no competing interests.
Authors’ contributions
Shengjie Yang and Mingchuan Liu performed the experiments, analyzed the
data and wrote the paper. Na Liang and Qi Zhao performed the
experiments. Yuping Zhang and Wei Xue planned and analyzed the data,
and Song Yang planned the experiments, wrote the paper and give finalapproval of the version to be published. All authors contributed to this
study, read and approved the final manuscript.Acknowledgements
The authors wish to thank the National Key Program for Basic Research
(Nos.2010CB126105, 2010CB134504), the National Natural Science
Foundation of China (Nos. 21132003, 21172048), Guizhou Province S&T
Program (No. 20103052) for the financial support.
Received: 16 December 2012 Accepted: 16 January 2013
Published: 4 February 2013References
1. Jiangsu New Medical College: Dictionary of Chinese Materia Medica.; 2001.
2. Socolsky C, Arena ME, Asakawa Y, Bardon A: Antibacterial prenylated
acylphloroglucinols from the fern Elaphoglossum yungense. J Nat Prod
2010, 73:1751–1755.
3. Kapadia GJ, Tokuda H, Konoshinma T: Anti-tumor promoting activity of
Dryopteris Phlorophenone derivatives. Cancer let 1996, 105:161–165.
4. Zhao ZL, Leng CH, Wang ZT: Identification of Dryiopteris crassirhizoma
and the adulterant species based on cpDNA rbcL and translated amino
acid sequences. Planta Med 2007, 73:1230–1233.
5. Ito H, Muranaka T: Ichthyotoxic pholroglucinol derivatives from Dryopteris
fragrans and their antitumor promoting acitivity. Chem Pharm Bull 2000,
48:1190–1192.
6. Attari F, Sepehri H, Delphi L, Goliaei B: Apoptotic and necrotic effects of
pectic acid on rat pituitary GH3/B6 tumor cells. Iran Bio J 2009,
13:229–236.
7. Shao JW, Dai YC, Xue JP, Wang JC, Lin FP, Guo YH: In vitro and in vivo
anticancer activity evaluation of ursolic acid derivatives. Eur J Med Chem
2011, 46:2652–2661.
8. Chiganças V, Miyaji EN, Muotri AR, de Fátima Jacysyn J, Amarante-Mendes
GP, Yasui A, Menck CF: Photorepair prevents ultraviolet-induced
apoptosis in human cells expressing the marsupial photolyase gene.
Cancer Res 2000, 60:2458–2463.
9. Bhattacharyya SS, Mandal SK, Biswas R, Paul S, Pathak S, Boujedaini N, Belon
P, Khuda-Bukhsh AR: In vitro studies demonstrate anticancer activity of
an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med 2008,
233:1591–1601.
10. Yuan K, Song B, Jin L, Xu S, Xu X, Yang S: Synthesis and biological
evaluation of novel 1-aryl, 5(phenoxy-substituted)aryl-1,4-pentadien-3-
one derivatives. Med Chem Commn 2011, 2:585–589.
11. Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E,
Green DR: Staining of suspension cells with hoechst 33258 to detect
apoptosis. SH Protoc 2006, 4:123–130.
12. Ribble D, Goldstein NB, Norris DA, Shellman YG: A simple technique for
quantifying apoptosis in 96-well plates. BMC Biotechnol 2005, 5:1–12.
13. Ariffin SHZ, Omar WHH, Ariffin ZZ, Safian MF: Intrinsic anticarcinogenic
effects of Piper sarmentosum ethanolic extract on a human hepatoma
cell line. Cancer Cell Int 2009, 9:1–6.
14. Meng C, Wu S, Xing D: Real-time fluorescence imaging of sirt1 cytosolic
translocation under the treatment of growth factor deprivation. J Innov
Opt Heal Sci 2011, 2:133–141.
15. Wu YL, Sun B, Zhang XJ, Wang SN, He HY, Qiao MM, Zhong J, Xu JY:
Growth inhibition and apoptosis induction of Sulindac on human gastric
cancer cells. World J Gastroenterol 2001, 7:796–800.
16. Zhang M, Zhang H, Sun C: Targeted constitutive activation of signal
transducer and activator of transcription 3 in human hepatocellular
carcinoma cells by cucurbitacin B. Cancer Chemoth Pharmacol 2009,
63:635–642.
17. Hashemi M, Karami-Tehrani F, Ghavami S, Maddika S, Los M: Adenosine and
deoxyadenosine induces apoptosis in oestrogen receptor-positive and
-negative human breast cancer cells via the intrinsic pathway. Cell Prolif
2005, 38:269–285.
18. Juan ME, Wenzel U, Ruiz-Gutierrez V, Daniel H, Planas JM: Olive fruit
extracts inhibit proliferation and induce apoptosis in HT-29 human colon
cancer cells. J Nutr 2006, 136:2553–2557.
19. Qing H, Xu H, Wei Z, Gibson K, Li XM: The ability of atypical antipsychotic
drugs vs. haloperidol to protect PC12 cells against MPP + -induced
apoptosis. Eur J Neurosci 2003, 17:1563–1570.
Yang et al. Chemistry Central Journal 2013, 7:24 Page 10 of 10
http://journal.chemistrycentral.com/content/7/1/2420. Li WB, Feng J, Geng SM, Zhang PY, Yang XN, Hu G: Induction of apoptosis
by Hax-1 siRNA in melanoma cells. Cell Biol Int 2009, 4:548–554.
21. Yuan Y, Bian JC, Liu XZ, Zhang Y, Sun Y, Liu ZP: Oxidative stress and
apoptotic changes of rat cerebral cortical neurons exposed to Cadmium
in vitro. Biomed Environ Sci 2012, 25:172–181.
22. Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T,
Lassmann H, Schulte-Hermann R: Condensation of the chromatin at the
membrane of an apoptotic nucleus is not associated with activation of
an endonuclease. J Cell Sci 1993, 104:317–326.
23. Popper P, Farber DB, Micevych PE, Minoofar K, Bronstein JM: TRPM-2
expression and tunel staining in neurodegenerative diseases: studies in
wobbler and rd mice. Exp Neurol 1997, 143:246–254.
24. Kundrotiene J, Wagner A, Liljequist S: Fluoro-Jade and TUNEL staining as
useful tools to identify ischemic brain damagefollowing moderate
extradural compression of sensorimotor cortex. Acta Neurobiol Exp 2004,
64:153–162.
25. Nishizaki K, Yoshino T, Orita Y, Nomiya S, Masuda Y: TUNEL staining of
inner ear structures may reflect autolysis, not apoptosis. Hear Res 1999,
130:131–136.
26. Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, Denburg
JA: Increased TUNEL staining in brains of autoimmune Fas-deficient
mice. J Neuroimmunol 2000, 104:147–154.
27. Orita Y, Nishizaki K, Sasaki J, Kanda S, Kimura N, Nomiya S, Yuen K, Masuda
Y: Does TUNEL staining during peri- and post-natal development of the
mouse inner ear indicate apoptosis? Acta Otolaryngol Suppl 1999,
540:22–26.
28. Herzenberg LA, Tung J, Moore WA, Herzenberg LA: Interpreting flow
cytometry data: a guide for the perplexed. Nat Immunol 2006, 7:681–685.
29. Stemberger J, Witt V, Printz D, Geyeregger R, Fritsch G: Novel single-
platform multiparameter FCM analysis of apoptosis: Significant
differences between wash and no-wash procedure. Cytom A 2010,
77:1075–1081.
30. Xu X, Liu J, Deng X: FCM, SSR and CAPS analysis of intergeneric somatic
hybrid plants between Changshou kumquat and Dancy tangerine. Bot
Bull Acad Sin 2005, 46:93–98.
31. Fujita M, Inoue T, Nagai M: O-methylation effect on the carbon-13 nuclear
magnetic resonance signals of ortho-substituted Phenols II. Yakugaku
Zasshi 1985, 105:240–243.
32. Murakami T, Chen CC: Uber die bestandteile der rhizome von
Woodwardia orientalis Sw. Chem Pharm Bull 1971, 19:25–30.
33. De Oliveira PES, Conserva LM, De Simone CA: A pimpinellin monomer and
dimer isolated from the roots of Esenbeckia grandiflora. Acta Cryst 2004,
C60:o900–o902.
34. Stenhagen E, Abrahamsson S, Fred WM: Registry of Mass Spectral Data. New
York, US: John wiley and Sons Inc; 1974.
35. Sliva MGV, Vieira IGP, Mendes FNP, Albuquerque IL, Santos RND: Variation
of ursolic acid content in eight ocimum species from northeastern Brazil.
Molecules 2008, 13:2482–2487.
36. Joshi KC, Bansal RK, Singh P: Mass & NMR spectral studies of sitost-4-en-3-
one from Tabebuia rosea DG. Indian J Chem 1974, 12:903.
37. Winston FT, Lynn CB, Azzam A: Lupanetriterpenoids of Salacia Cordata.
J Nat Prod 1992, 3:395–398.
38. Itokawa H, Suto K, Takeya K: Studies on a novel P-coumaroyl glucoside of
apigenin and on other flavonoids isolated from Patchouli. Chem Pharm
Bull 1981, 29:254–256.
39. Murakami T, Chen CM: Uber die bestandteile der rhizome von
Woodwardia orientalis Sw. Chem Pharm Bull 1971, 19:25.
40. Mizuno M, Iinuma M, Tanaka T: Sutchuenoside A: A New kempferol
glycoside from the aerial parts of Epimedium Sutchuenense. J Nat Prod
1991, 54:1427–1429.
41. Toker G, Memisoglu M, Yesilada E, Aslan M: Main flavonoid of Tilia
argentea DESF. ex DC. leaves. Turk J Chem 2004, 28:745–749.
42. Gen IN: A new class of dimeric flavan-3-ol gallates, theasinensins A and
B, and proanthocyanidin gallates from green tea leaf. Chem Pharm Bull
1983, 31:3906–3914.
43. Tanaka T, Nonaka G, Nishioka I: 7-O-galloyl-(+)-catechin and 3-O-galloyl
procyanidin B-3 from Sanguisorba officinalis. Phytochemistry 1983,
22:2575–2578.
44. Hu XL, Zhu H, Liu CR, Tu PF: Study on the chemical constituents of the
flowers of Impatiens balsamina L. Chin Tradit Patent Med 2003, 25:833–834.45. Li LM, Pu JX, Xiao WL, Sun HD: Triterpenes from Isodon xerophilus. Chin J
Nat Med 2002, 10:307–310.
46. Fang SY, He AS, Gao JF: Triterpenoids from Adina rubella. J Nat Prod 1996,
59:304–307.
47. Byung SM, Miyuki T, MA CM, Norio N, Masao H: Kaempferol
acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and
their inhibitory effects on three different activities of human
immunodeficiency virus-1 reverse transcriptase. Chem Pharm Bull 2001,
49:546–550.
48. Masuda T, Jitoe A, Kato S: Acetylated flavonol glycosides from Zingiber
zerumbet. Phytochemistry 1991, 30:2391–2394.
49. Jinsaku S, Toyo K, Haruyo F, Toyokazu O: 6β-hydroxyursolic acid and other
triterpenoids of Enkianthus cernuus. Phytochemistry 1983, 22:2553–2555.
50. Luan X, Wang H, Wen YY: Studies on the chemical constituents of
Woodwardia japonica. J Trop Subtrop Botany 2002, 10:361–365.
51. Dehelean CA, Şoica C, Ledeţi I, Aluaş M, Zupko I, Gǎluşcan A, Cinta-Pinzaru
S, Munteanu M: Study of the betulin enriched birch bark extracts effects
on human carcinoma cells and ear inflammation. Chem Cent J 2012,
6:137.
doi:10.1186/1752-153X-7-24
Cite this article as: Yang et al.: Discovery and antitumor activities of
constituents from Cyrtomium fortumei (J.) Smith rhizomes. Chemistry
Central Journal 2013 7:24.Open access provides opportunities to our 
colleagues in other parts of the globe, by allowing 
anyone to view the content free of charge.
Publish with ChemistryCentral and every
scientist can read your work free of charge
W. Jeffery Hurst, The Hershey Company.
available free of charge to the entire scientific community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours     you keep the copyright
Submit your manuscript here:
http://www.chemistrycentral.com/manuscript/
